Duchenne muscular dystrophy is being transformed by gene therapy. But success underscores a need to find ways to redose as the effects fade.May 4, 2023Check out STAT+Sponsored By Courtesy Jess & Chris Curran STAT+ | Gene therapy has helped boys like Conner walk. Scientists are trying to keep it that way Duchenne muscular dystrophy is being transformed by gene therapy. But success underscores a need to find ways to redose as the effects fade. By Jason Mast Covid and mpox are here to stay, but the WHO's emergencies may be nearing an end Some global health experts say that while the diseases still pose threats, the time has come for the WHO to end its emergencies. By Helen Branswell Amid booming demand, Novo to hold back some doses of obesity drug Wegovy for new U.S. patients The company said would temporarily limit some "starter" doses for new patients in the U.S. to ensure a supply for people already on the drug. By Andrew Joseph American Heart Association In a first, a potentially fatal rare blood vessel disorder is treated in the womb Since her birth, the infant hasn't needed drugs to treat heart failure, or postnatal surgery to treat the malformation, as is often the case. By Ambar Castillo STAT+ | Option Care takes over Amedisys in 'perplexing' $3.6 billion home care deal Option Care Health is buying Amedisys, creating a national company that specializes in almost all types of home care. By Bob Herman STAT+ | NIH systems for non-human primate research fall short, threatening biomedical research "Now is the time to strengthen the systems we need for nonhuman primate research," said Kenneth Ramos, whose NASEM committee issued the report. By Ed Silverman Sarah Gonzalez for STAT 12,000 diseases lack treatments. One doctor thinks generics could yield cures A doctor who saved his own life by turning to a generic is starting to use AI to search for other hidden cures in the pharmacopeia. By Isabella Cueto STAT+ | New Eli Lilly Alzheimer's data poses Medicare coverage conundrum Eli Lilly's new data on its anti-amyloid Alzheimer's treatment ratchets up the pressure on Medicare's unprecedented restrictions on coverage. By Rachel Cohrs STAT+ | A new list ranks large pharmaceutical companies by research and development Here's a look at the annual list produced by Idea Pharma and called the Pharmaceutical Innovation and Invention Index. By Matthew Herper More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments